Hancock Whitney’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,615
| Closed | -$229K | – | 650 |
|
|
2023
Q1 | $229K | Sell |
5,615
-756
| -12% | -$30.8K | 0.01% | 593 |
|
|
2022
Q4 | $246K | Sell |
6,371
-75
| -1% | -$2.9K | 0.01% | 568 |
|
|
2022
Q3 | $343K | Buy |
6,446
+944
| +17% | +$50.2K | 0.01% | 493 |
|
|
2022
Q2 | $321K | Sell |
5,502
-233
| -4% | -$13.6K | 0.01% | 529 |
|
|
2022
Q1 | $438K | Sell |
5,735
-1,271
| -18% | -$97.1K | 0.01% | 501 |
|
|
2021
Q4 | $422K | Sell |
7,006
-51
| -0.7% | -$3.07K | 0.01% | 514 |
|
|
2021
Q3 | $395K | Buy |
7,057
+41
| +0.6% | +$2.3K | 0.01% | 525 |
|
|
2021
Q2 | $426K | Sell |
7,016
-150
| -2% | -$9.11K | 0.01% | 598 |
|
|
2021
Q1 | $502K | Sell |
7,166
-116
| -2% | -$8.13K | 0.02% | 547 |
|
|
2020
Q4 | $436K | Sell |
7,282
-27
| -0.4% | -$1.62K | 0.01% | 566 |
|
|
2020
Q3 | $439K | Buy |
7,309
+285
| +4% | +$17.1K | 0.02% | 537 |
|
|
2020
Q2 | $369K | Sell |
7,024
-2,625
| -27% | -$138K | 0.01% | 575 |
|
|
2020
Q1 | $324K | Buy |
+9,649
| New | +$324K | 0.01% | 618 |
|